The benefit of using CT-perfusion imaging for reliable response monitoring in patients with gastrointestinal stromal tumor (GIST) undergoing treatment with novel targeted agents

Betz, Martina; Kopp, Hans Georg; Spira, Daniel; Claussen, Claus D.; Horger, Marius

dc.contributor.author	Betz, Martina
dc.contributor.author	Spira, Daniel
dc.contributor.author	Claussen, Claus
dc.contributor.author	Horger, Marius Stefan
dc.contributor.author	Kopp, Hans-Georg
dc.date.accessioned	2014-02-20T07:17:10Z
dc.date.available	2014-02-20T07:17:10Z
dc.date.issued	2013
dc.identifier.issn	0284-1851
dc.identifier.uri	http://hdl.handle.net/10900/41860
dc.language.iso	en	en
dc.publisher	Royal Soc Medicine Press Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1177/0284185113484642	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	The benefit of using CT-perfusion imaging for reliable response monitoring in patients with gastrointestinal stromal tumor (GIST) undergoing treatment with novel targeted agents	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140116051827_00936	de_DE
utue.publikation.seiten	711-721	de_DE
utue.personen.roh	Betz, Martina
utue.personen.roh	Kopp, Hans Georg
utue.personen.roh	Spira, Daniel
utue.personen.roh	Claussen, Claus D.
utue.personen.roh	Horger, Marius
dcterms.isPartOf.ZSTitelID	Acta Radiologica	de_DE
dcterms.isPartOf.ZS-Issue	7	de_DE
dcterms.isPartOf.ZS-Volume	54	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE